nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—TSPO—exocrine gland—cervical cancer	0.0385	0.0909	CbGeAlD
Zaleplon—Intestinal obstruction—Topotecan—cervical cancer	0.0271	0.0471	CcSEcCtD
Zaleplon—Neuralgia—Topotecan—cervical cancer	0.0266	0.0462	CcSEcCtD
Zaleplon—Pleural effusion—Topotecan—cervical cancer	0.0241	0.0419	CcSEcCtD
Zaleplon—Dysmenorrhoea—Topotecan—cervical cancer	0.0203	0.0353	CcSEcCtD
Zaleplon—Hyperbilirubinaemia—Topotecan—cervical cancer	0.0203	0.0353	CcSEcCtD
Zaleplon—AOX1—uterine cervix—cervical cancer	0.0194	0.0459	CbGeAlD
Zaleplon—AOX1—decidua—cervical cancer	0.0185	0.0437	CbGeAlD
Zaleplon—Pulmonary embolism—Topotecan—cervical cancer	0.0185	0.0321	CcSEcCtD
Zaleplon—AOX1—renal system—cervical cancer	0.0182	0.0429	CbGeAlD
Zaleplon—Colitis—Topotecan—cervical cancer	0.0178	0.0308	CcSEcCtD
Zaleplon—AOX1—endometrium—cervical cancer	0.0176	0.0415	CbGeAlD
Zaleplon—Neuropathy—Topotecan—cervical cancer	0.0174	0.0301	CcSEcCtD
Zaleplon—AOX1—mammalian vulva—cervical cancer	0.017	0.0402	CbGeAlD
Zaleplon—Rash maculo-papular—Topotecan—cervical cancer	0.0168	0.0292	CcSEcCtD
Zaleplon—TSPO—epithelium—cervical cancer	0.0168	0.0395	CbGeAlD
Zaleplon—TSPO—uterine cervix—cervical cancer	0.0166	0.0392	CbGeAlD
Zaleplon—AOX1—uterus—cervical cancer	0.0162	0.0383	CbGeAlD
Zaleplon—TSPO—decidua—cervical cancer	0.0158	0.0374	CbGeAlD
Zaleplon—Ear pain—Topotecan—cervical cancer	0.0157	0.0273	CcSEcCtD
Zaleplon—TSPO—renal system—cervical cancer	0.0155	0.0367	CbGeAlD
Zaleplon—TSPO—endometrium—cervical cancer	0.015	0.0355	CbGeAlD
Zaleplon—AOX1—female reproductive system—cervical cancer	0.0146	0.0344	CbGeAlD
Zaleplon—TSPO—mammalian vulva—cervical cancer	0.0145	0.0343	CbGeAlD
Zaleplon—Dermatitis bullous—Topotecan—cervical cancer	0.014	0.0244	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Topotecan—cervical cancer	0.0139	0.0241	CcSEcCtD
Zaleplon—TSPO—uterus—cervical cancer	0.0138	0.0327	CbGeAlD
Zaleplon—AOX1—female gonad—cervical cancer	0.0133	0.0313	CbGeAlD
Zaleplon—AOX1—vagina—cervical cancer	0.0132	0.0311	CbGeAlD
Zaleplon—TSPO—female reproductive system—cervical cancer	0.0124	0.0294	CbGeAlD
Zaleplon—GABRA2—vagina—cervical cancer	0.0122	0.0287	CbGeAlD
Zaleplon—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.0121	0.021	CcSEcCtD
Zaleplon—Alanine aminotransferase increased—Topotecan—cervical cancer	0.0118	0.0205	CcSEcCtD
Zaleplon—TSPO—female gonad—cervical cancer	0.0113	0.0267	CbGeAlD
Zaleplon—GABRB3—female reproductive system—cervical cancer	0.0113	0.0267	CbGeAlD
Zaleplon—TSPO—vagina—cervical cancer	0.0113	0.0266	CbGeAlD
Zaleplon—Weight increased—Topotecan—cervical cancer	0.0106	0.0183	CcSEcCtD
Zaleplon—Pneumonia—Topotecan—cervical cancer	0.0104	0.0181	CcSEcCtD
Zaleplon—CYP3A5—uterine cervix—cervical cancer	0.0103	0.0243	CbGeAlD
Zaleplon—Neuropathy peripheral—Topotecan—cervical cancer	0.0101	0.0176	CcSEcCtD
Zaleplon—Stomatitis—Topotecan—cervical cancer	0.0101	0.0175	CcSEcCtD
Zaleplon—Sweating—Topotecan—cervical cancer	0.00992	0.0172	CcSEcCtD
Zaleplon—Hepatobiliary disease—Topotecan—cervical cancer	0.00978	0.017	CcSEcCtD
Zaleplon—Epistaxis—Topotecan—cervical cancer	0.00976	0.0169	CcSEcCtD
Zaleplon—CYP3A5—renal system—cervical cancer	0.00963	0.0227	CbGeAlD
Zaleplon—Hypoaesthesia—Topotecan—cervical cancer	0.00924	0.016	CcSEcCtD
Zaleplon—AOX1—lymph node—cervical cancer	0.00852	0.0201	CbGeAlD
Zaleplon—Immune system disorder—Topotecan—cervical cancer	0.00839	0.0146	CcSEcCtD
Zaleplon—Chills—Topotecan—cervical cancer	0.00833	0.0145	CcSEcCtD
Zaleplon—Alopecia—Topotecan—cervical cancer	0.00821	0.0142	CcSEcCtD
Zaleplon—Malnutrition—Topotecan—cervical cancer	0.00808	0.014	CcSEcCtD
Zaleplon—GABRA2—lymph node—cervical cancer	0.00787	0.0186	CbGeAlD
Zaleplon—Back pain—Topotecan—cervical cancer	0.00782	0.0136	CcSEcCtD
Zaleplon—Ill-defined disorder—Topotecan—cervical cancer	0.0075	0.013	CcSEcCtD
Zaleplon—Anaemia—Topotecan—cervical cancer	0.00747	0.013	CcSEcCtD
Zaleplon—Angioedema—Topotecan—cervical cancer	0.00739	0.0128	CcSEcCtD
Zaleplon—Malaise—Topotecan—cervical cancer	0.00729	0.0126	CcSEcCtD
Zaleplon—TSPO—lymph node—cervical cancer	0.00728	0.0172	CbGeAlD
Zaleplon—CYP3A4—renal system—cervical cancer	0.00722	0.017	CbGeAlD
Zaleplon—CYP3A5—female gonad—cervical cancer	0.00701	0.0166	CbGeAlD
Zaleplon—CYP3A5—vagina—cervical cancer	0.00697	0.0165	CbGeAlD
Zaleplon—Myalgia—Topotecan—cervical cancer	0.00688	0.0119	CcSEcCtD
Zaleplon—Chest pain—Topotecan—cervical cancer	0.00688	0.0119	CcSEcCtD
Zaleplon—Arthralgia—Topotecan—cervical cancer	0.00688	0.0119	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00683	0.0119	CcSEcCtD
Zaleplon—Discomfort—Topotecan—cervical cancer	0.0068	0.0118	CcSEcCtD
Zaleplon—Anaphylactic shock—Topotecan—cervical cancer	0.0066	0.0114	CcSEcCtD
Zaleplon—Nervous system disorder—Topotecan—cervical cancer	0.00647	0.0112	CcSEcCtD
Zaleplon—Skin disorder—Topotecan—cervical cancer	0.00641	0.0111	CcSEcCtD
Zaleplon—Hyperhidrosis—Topotecan—cervical cancer	0.00638	0.0111	CcSEcCtD
Zaleplon—Anorexia—Topotecan—cervical cancer	0.00629	0.0109	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00601	0.0104	CcSEcCtD
Zaleplon—Paraesthesia—Topotecan—cervical cancer	0.00592	0.0103	CcSEcCtD
Zaleplon—Dyspnoea—Topotecan—cervical cancer	0.00588	0.0102	CcSEcCtD
Zaleplon—Dyspepsia—Topotecan—cervical cancer	0.00581	0.0101	CcSEcCtD
Zaleplon—CYP3A4—female reproductive system—cervical cancer	0.00579	0.0137	CbGeAlD
Zaleplon—Decreased appetite—Topotecan—cervical cancer	0.00573	0.00995	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Topotecan—cervical cancer	0.0057	0.00988	CcSEcCtD
Zaleplon—Pain—Topotecan—cervical cancer	0.00564	0.00979	CcSEcCtD
Zaleplon—Constipation—Topotecan—cervical cancer	0.00564	0.00979	CcSEcCtD
Zaleplon—Feeling abnormal—Topotecan—cervical cancer	0.00544	0.00943	CcSEcCtD
Zaleplon—Gastrointestinal pain—Topotecan—cervical cancer	0.00539	0.00936	CcSEcCtD
Zaleplon—Urticaria—Topotecan—cervical cancer	0.00524	0.00909	CcSEcCtD
Zaleplon—Abdominal pain—Topotecan—cervical cancer	0.00521	0.00905	CcSEcCtD
Zaleplon—Body temperature increased—Topotecan—cervical cancer	0.00521	0.00905	CcSEcCtD
Zaleplon—Asthenia—Topotecan—cervical cancer	0.00473	0.00821	CcSEcCtD
Zaleplon—Pruritus—Topotecan—cervical cancer	0.00467	0.0081	CcSEcCtD
Zaleplon—Dizziness—Topotecan—cervical cancer	0.00436	0.00757	CcSEcCtD
Zaleplon—Rash—Topotecan—cervical cancer	0.00416	0.00722	CcSEcCtD
Zaleplon—Dermatitis—Topotecan—cervical cancer	0.00416	0.00721	CcSEcCtD
Zaleplon—Headache—Topotecan—cervical cancer	0.00413	0.00717	CcSEcCtD
Zaleplon—Nausea—Topotecan—cervical cancer	0.00392	0.0068	CcSEcCtD
